129 related articles for article (PubMed ID: 38108354)
1. Prevalence and Associations of Cognitive Impairment in Adult Patients with Moyamoya Disease: A Systematic Review and Meta-Analysis.
Toh KZX; Koh MY; Loh EDW; Sia CH; Chong Y; Yeo LLL; Sharma VK; Lim MJR; Tan BYQ
J Alzheimers Dis; 2024; 97(2):541-552. PubMed ID: 38108354
[TBL] [Abstract][Full Text] [Related]
2. Association of cognitive function and hypoperfusion in Moyamoya disease patients without stroke.
Shen XX; Zhang HD; Fu HG; Xu JL; Zhang HT; Hou L; Zou ZX; Li B; Hao FB; Duan L; Han C
J Cereb Blood Flow Metab; 2023 Apr; 43(4):542-551. PubMed ID: 36397212
[TBL] [Abstract][Full Text] [Related]
3. Intravenous thrombolysis and endovascular thrombectomy for acute ischaemic stroke in patients with Moyamoya disease - a systematic review and meta-summary of case reports.
Koh MY; Toh KZ; Ho JS; Yeo LL; Ho AF; Sia CH; Tan BY
J Thromb Thrombolysis; 2022 Aug; 54(2):339-349. PubMed ID: 35699873
[TBL] [Abstract][Full Text] [Related]
4. White matter hyperintensities in cholinergic pathways correlates of cognitive impairment in moyamoya disease.
Xu D; Yu X; Hu J; Yu Y; Wang L; Jiang B; Zhang M
Eur Radiol; 2024 Jul; 34(7):4596-4606. PubMed ID: 38092950
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of cognitive impairment in adult asymptomatic moyamoya disease.
He S; Duan R; Liu Z; Ye X; Yuan L; Li T; Tan C; Shao J; Qin S; Wang R
BMC Neurol; 2020 Aug; 20(1):322. PubMed ID: 32867701
[TBL] [Abstract][Full Text] [Related]
6. Association of moyamoya vasculopathy with autoimmune disease: a systematic review and pooled analysis.
Singh R; Bauman MMJ; Seas A; Harrison DJ; Pennington Z; Brown NJ; Gendreau J; Rahmani R; Ellens N; Catapano J; Lawton MT
Neurosurg Rev; 2023 Sep; 46(1):220. PubMed ID: 37658996
[TBL] [Abstract][Full Text] [Related]
7. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya.
Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N
Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345
[TBL] [Abstract][Full Text] [Related]
8. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet Treatment in Moyamoya Disease: A Systematic Review.
Kijpaisalratana N; Ariyaprakai C; Sriamornrattanakul K; Wongsuriyanan S; Akharathammachote N; Susantitaphong P; Suwanwela NC
Cerebrovasc Dis Extra; 2024; 14(1):76-85. PubMed ID: 38697036
[TBL] [Abstract][Full Text] [Related]
10. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
[TBL] [Abstract][Full Text] [Related]
11. Predictors of preoperative cognitive dysfunction in adults with Moyamoya disease: a preliminary research.
Sun J; Shi Z; Yu L; Wen Y; Zhang D
BMC Neurol; 2022 Jan; 22(1):12. PubMed ID: 34991523
[TBL] [Abstract][Full Text] [Related]
12. Comparison between moyamoya disease and moyamoya syndrome in Israel.
Schwartzmann Y; Spektor S; Moscovici S; Jubran H; Metanis I; Jouaba T; Cohen JE; Gomori JM; Leker RR
J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107635. PubMed ID: 38342272
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for postoperative stroke in adults patients with moyamoya disease: a systematic review with meta-analysis.
Wei W; Chen X; Yu J; Li XQ
BMC Neurol; 2019 May; 19(1):98. PubMed ID: 31092214
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.
Khan NI; Saherwala AA; Chen M; Salehian S; Salahuddin H; Welch BG; Pinho MC; Shang T
Cerebrovasc Dis Extra; 2019; 9(3):139-147. PubMed ID: 31830749
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the association between RNF213 polymorphisms and clinical features of moyamoya disease in Asian population.
Jiang X; Liu L; Ai S; Xie X; Deng J; Jiang Z; Teng B; Liu C; Huang H
Clin Neurol Neurosurg; 2023 Aug; 231():107801. PubMed ID: 37267801
[TBL] [Abstract][Full Text] [Related]
16. Atrial Fibrillation Is Associated with Cognitive Impairment, All-Cause Dementia, Vascular Dementia, and Alzheimer's Disease: a Systematic Review and Meta-Analysis.
Papanastasiou CA; Theochari CA; Zareifopoulos N; Arfaras-Melainis A; Giannakoulas G; Karamitsos TD; Palaiodimos L; Ntaios G; Avgerinos KI; Kapogiannis D; Kokkinidis DG
J Gen Intern Med; 2021 Oct; 36(10):3122-3135. PubMed ID: 34244959
[TBL] [Abstract][Full Text] [Related]
17. Associations of depression, anxiety and PTSD with neurological disability and cognitive impairment in survivors of moyamoya disease.
Liu C; Yi X; Li T; Xu L; Hu M; Zhang S; Jiang R
Psychol Health Med; 2019 Jan; 24(1):43-50. PubMed ID: 29678126
[TBL] [Abstract][Full Text] [Related]
18. Cerebrovascular events after surgery versus conservative therapy for moyamoya disease: a meta-analysis.
Wouters A; Smets I; Van den Noortgate W; Steinberg GK; Lemmens R
Acta Neurol Belg; 2019 Sep; 119(3):305-313. PubMed ID: 31215004
[TBL] [Abstract][Full Text] [Related]
19. Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease.
Chen JB; Liu Y; Zhou LX; Sun H; He M; You C
J Neurosurg; 2016 May; 124(5):1215-20. PubMed ID: 26406790
[TBL] [Abstract][Full Text] [Related]
20. Neurocognitive impairment in adults with moyamoya disease without stroke.
Karzmark P; Zeifert PD; Bell-Stephens TE; Steinberg GK; Dorfman LJ
Neurosurgery; 2012 Mar; 70(3):634-8. PubMed ID: 21849919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
